2009. Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. Hematology Meeting Reports (formerly Haematologica Reports). 1, 6 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v1i6.675.